MICROBIOME INDICATIONS

MICROBIOME INDICATIONS

Our integrated platform for strain selection, cGMP manufacturing and development and targeted Gemicel® delivery allow Assembly to rapidly and efficiently address additional therapeutic indications, both on our own and with a variety of partners.

ASMB MICROBIOME PLATFORM FOR THERAPEUTIC AREA EXPANSION

Gastro
  • IBD
  • Crohn's
  • Ulcerative
    Colitis
  • IBS
Oncology
  • Immunoncology
Liver
  • NASH
Metabolic Disease
  • Obesity
  • Diabetes/Prediabetes
Infectious Disease
  • CDI